background
drug
current
licens
treat
influenza
infect
new
therapi
need
especi
highli
pathogen
strain
tradit
medicin
plant
lycori
radiata
potenti
sourc
new
antivir
agent
object
test
amaryllidacea
alkaloid
isol
bulb
l
radiata
vitro
antivir
activ
influenza
viru
type
chicken
guangdong
method
antivir
activ
compound
test
timeofaddit
assay
hemagglutin
inhibit
hi
assay
neuraminidas
na
activ
assay
viral
entri
inhibit
assay
use
pseudovirus
effect
compound
local
activ
viral
ribonucleoprotein
rnp
determin
immunofluoresc
rnp
minigenom
assay
respect
result
among
alkaloid
lycorin
hippeastrin
hemanthamin
vittatin
exhibit
antivir
activ
ec
valu
lm
respect
compound
affect
function
outer
membran
protein
viral
entri
process
viral
rnp
activ
exhibit
stronger
antivir
activ
analyz
intracellular
nucleoprotein
np
local
show
inhibit
rnp
complex
nucleu
earli
stage
singleround
multiround
replic
conclus
four
amaryllidacea
alkaloid
first
determin
could
exert
antiinfluenza
activ
viru
entri
cell
furthermor
could
inhibit
nucleartocytoplasm
export
rnp
complex
viru
replic
thu
compound
may
develop
antiinfluenza
drug
candid
keyword
amaryllidacea
alkaloid
influenza
viru
vrnp
export
pleas
cite
paper
et
al
amaryllidacea
alkaloid
inhibit
nucleartocytoplasm
export
ribonucleoprotein
rnp
complex
highli
pathogen
avian
influenza
viru
influenza
respiratori
virus
author
contribut
equal
paper
method
antivir
activ
compound
test
timeofaddit
assay
hemagglutin
inhibit
hi
assay
neuraminidas
na
activ
assay
viral
entri
inhibit
assay
use
pseudovirus
effect
compound
local
activ
viral
ribonucleoprotein
rnp
determin
immunofluoresc
rnp
minigenom
assay
respect
result
among
alkaloid
lycorin
hippeastrin
hemanthamin
vittatin
exhibit
antivir
activ
ec
valu
lm
respect
compound
affect
function
outer
membran
protein
viral
entri
process
viral
rnp
activ
exhibit
stronger
antivir
activ
analyz
intracellular
nucleoprotein
np
local
show
inhibit
rnp
complex
nucleu
earli
stage
singleround
multiround
replic
conclus
four
amaryllidacea
alkaloid
first
determin
could
exert
antiinfluenza
activ
viru
entri
cell
furthermor
could
inhibit
nucleartocytoplasm
export
rnp
complex
viru
replic
thu
compound
may
develop
antiinfluenza
drug
candid
keyword
amaryllidacea
alkaloid
influenza
viru
vrnp
export
pleas
cite
paper
et
al
amaryllidacea
alkaloid
inhibit
nucleartocytoplasm
export
ribonucleoprotein
rnp
complex
highli
pathogen
avian
influenza
viru
influenza
respiratori
virus
avian
influenza
viru
aiv
negativesens
segment
singlestrand
rna
viru
belong
orthomyxovirida
famili
global
aiv
occasion
caus
infect
human
livestock
poultri
pig
wild
anim
harm
outcom
highli
pathogen
aiv
hpaiv
strain
particular
occasion
infect
human
high
mortal
rate
exceed
consequ
high
rate
antigen
drift
shift
reassort
strain
novel
mutant
emerg
acquir
abil
crossspeci
barrier
becom
pathogen
new
host
efficaci
practic
time
vaccin
remain
problemat
worldwid
effort
combat
influenza
strain
resist
drug
eg
amantadin
often
appear
thu
far
four
antivir
agent
approv
us
food
drug
administr
fda
treat
influenza
viru
infect
divid
two
group
one
compris
ionchannel
inhibitor
amantadin
rimantadin
interfer
viral
uncoat
within
host
cell
inhibitor
effect
influenza
viru
associ
sever
toxic
effect
digest
nervou
system
group
consist
drug
oseltamivir
zanamivir
neuraminidas
na
inhibitor
although
oseltamivir
zanamivir
high
antivir
activ
low
bioavail
advers
effect
nausea
vomit
light
issu
new
class
drug
urgent
need
suitabl
longterm
use
tradit
medicin
plant
potenti
sourc
new
antivir
agent
bulb
lycori
radiata
long
use
tradit
chines
medicin
treatment
laryng
complic
furuncl
carbuncl
suppur
wound
previou
phytochem
pharmacolog
studi
reveal
major
chemic
constitu
plant
alkaloid
demonstr
antivir
antitumor
antimalari
acetylcholinesteraseinhibitori
activ
obtain
specif
antiaiv
compound
total
alkaloid
l
radiata
separ
purifi
use
chromatograph
method
group
fifteen
alkaloid
isol
identifi
basi
extens
spectroscop
analysi
among
four
compound
lycorin
hippeastrin
hemanthamin
vittatin
exhibit
inhibitori
activ
strain
mardindarbi
canin
kidney
mdck
cell
current
studi
investig
antiaiv
activ
amaryllidacea
alkaloid
mode
action
activ
compound
infect
experi
vitro
indic
could
inhibit
nucleartocytoplasm
export
rnp
complex
singleround
multiround
replic
assay
could
possibl
mechan
antivir
activ
therefor
compound
may
develop
antiinfluenza
drug
candid
bulb
l
radiata
collect
lanxi
citi
zhejiang
provinc
china
identifi
minjian
qin
depart
pharmacognosi
china
pharmaceut
univers
nanj
p
r
china
voucher
specimen
deposit
herbarium
china
pharmaceut
univers
isol
procedur
alkaloid
l
radiata
previous
describ
alkaloid
fraction
subject
repeat
column
chromatographi
silica
gel
sephadex
prephplc
yield
lycorin
hippeastrin
hemanthamin
vittatin
lycorenin
dihydrolycorin
lycoramin
galanthamin
galanthin
omethyllycorenin
odemethylycoramin
demethymaritidin
ungeremin
trisphaeridin
chemic
structur
determin
spectroscop
analys
comparison
publish
data
puriti
compound
determin
highperform
liquid
chromatographi
hplc
puriti
nuclear
magnet
reson
nmr
spectroscopi
structur
compound
display
figur
compound
bioassay
dissolv
dmso
oseltamivir
carboxyl
kindli
provid
hoffmannla
roch
cytotox
cellbas
antivir
activ
amaryllidacea
alkaloid
oseltamivir
evalu
use
assay
cytotox
analysi
mdck
cell
plate
cell
plate
corn
ny
usa
incub
serial
twofold
dilut
amaryllidacea
alkaloid
contain
dmso
dmem
incub
h
solut
dojindo
chemic
kumamoto
japan
ad
well
plate
cell
incub
moi
viru
h
remov
wash
pb
three
time
follow
addit
serial
twofold
dilut
amaryllidacea
alkaloid
concentr
lower
cytotox
concentr
cc
per
well
incub
h
solut
ad
well
plate
optic
densiti
od
absorb
measur
h
later
scan
nm
refer
use
biotek
micropl
reader
molecular
devic
winooski
vt
usa
three
independ
experi
carri
experi
perform
triplic
percentag
viabl
cell
compar
untreat
control
plot
concentr
four
compound
linear
regress
analysi
perform
use
microsoft
excel
softwar
calcul
cc
ha
titer
use
test
effect
concentr
ec
ec
select
index
si
amaryllidacea
alkaloid
tabl
calcul
divid
cc
ec
cc
ec
detect
antivir
activ
compound
test
pretreat
simultan
treatment
posttreat
activ
compound
chose
experi
explor
mechan
antivir
activ
compound
seven
differ
protocol
deliveri
use
mdck
cell
first
seed
plate
cell
well
grown
h
variou
protocol
carri
follow
neg
control
supernat
replac
four
compound
lm
lm
lm
lm
h
posit
control
viru
adsorpt
moi
three
wash
pb
incub
dmem
confirm
whether
compound
compet
viru
bind
influenza
viru
receptor
viru
mix
compound
incub
h
inocul
onto
cell
h
remov
wash
cultiv
cultur
medium
without
drug
protocol
postinfect
treatment
viru
absorb
h
supernat
replac
drugdmem
determin
whether
compound
compet
viru
bind
receptor
host
cell
viru
variou
compound
ad
togeth
cell
h
supernat
replac
without
drug
h
protocol
oseltamivir
lm
ad
viru
entri
drug
control
group
ha
titer
test
hemagglutinin
agglutin
assay
supernat
seven
protocol
collect
differ
time
point
h
test
human
rna
polymeras
promot
mous
rna
polymeras
termin
obtain
plasmid
pdl
obtain
key
laboratori
anim
diseas
control
prevent
ministri
agricultur
pr
china
primer
use
amplif
contain
ecori
psti
site
poli
vector
gener
insert
promot
termin
pgemt
vector
luciferas
gene
amplifi
plasmid
control
vector
promega
madison
wi
usa
pcr
amplif
luciferas
gene
fluc
clone
antisens
orient
flank
noncod
region
segment
influenza
viru
pr
site
poliprofluct
gener
polifluc
plasmid
fulllength
cdna
pa
np
clone
pdl
digest
viral
rnp
complex
play
import
role
viral
gener
replic
pathogen
determin
whether
amaryllidacea
alkaloid
compound
inhibit
viru
replic
via
rnp
four
express
plasmid
pa
np
ng
viru
strain
cotransfect
cell
plate
togeth
polifluc
ng
express
firefli
luciferas
intern
control
plasmid
prltk
ng
express
renilla
luciferas
promega
co
h
transfect
supernat
replac
media
contain
amaryllidacea
alkaloid
compound
indic
concentr
lm
h
transfect
cell
collect
detect
luciferas
activ
promega
use
geniu
pro
luminomet
pretreat
simultan
treatment
posttreat
mdck
cell
rel
viru
infect
use
determin
stage
viral
life
cycl
affect
compound
four
amaryllidacea
alkaloid
compound
assay
viru
inhibit
triplic
h
incub
antivir
assay
ha
titer
determin
monolay
mdck
cell
grown
plate
inocul
influenza
viru
moi
plate
incub
h
ensur
virus
would
replic
synchron
time
viru
adsorpt
period
without
compound
differ
indic
time
interv
adsorpt
period
figur
cultur
frozen
viru
yield
determin
ha
titer
hi
assay
carri
describ
ehrhardt
et
al
briefli
serial
twofold
dilut
four
amaryllidacea
alkaloid
compound
prepar
mix
equal
volum
influenza
viru
suspens
ha
unit
incub
h
v
v
chicken
erythrocyt
pb
ad
four
sampl
incub
min
room
temperatur
na
activ
measur
fluorescencebas
assay
use
neuraminidas
inhibitor
screen
kit
beyotim
institut
biotechnolog
hai
men
citi
jiang
su
provinc
china
ten
microlit
solut
purifi
na
ad
detect
buffer
test
compound
serial
twofold
dilut
ad
min
follow
addit
na
substrat
min
fluoresc
intens
measur
excit
wavelength
nm
emiss
wavelength
nm
use
micropl
reader
genio
pro
tecan
mannedorf
seestrass
switzerland
prepar
cell
confoc
microscopi
examin
stage
viral
infect
target
compound
mdck
cell
plate
dmem
use
exponenti
growth
phase
cell
expos
viru
strain
replic
influenza
viru
inhibit
four
activ
compound
viru
entri
eleven
compound
possess
antivir
activ
pretreat
simultan
treatment
posttreat
test
activ
compound
detail
explor
antivir
activ
si
valu
calcul
classifi
select
molecul
inact
si
weak
si
moder
si
strong
si
inhibitor
tabl
ec
valu
oseltamivir
compound
respect
test
abil
amaryllidacea
alkaloid
prevent
attach
influenza
viru
mdck
cell
ad
compound
prior
pretreat
simultan
viru
infect
cell
pretreat
ha
titer
inhibit
data
shown
result
show
antivir
effect
compound
influenza
due
prevent
viru
attach
alter
cell
receptor
simultan
treatment
result
also
show
antivir
effect
influenza
viru
target
viral
surfac
protein
viru
replic
inhibit
treat
four
amaryllidacea
alkaloid
compound
exhibit
higher
antivir
activ
ha
titer
test
determin
effect
releas
total
viru
particl
infect
cell
treat
infect
cell
amaryllidacea
alkaloid
compound
multipl
replic
cycl
seven
differ
protocol
shown
figur
cultur
dmemcontain
compound
protocol
ha
titer
strong
inhibit
ha
titer
detect
ha
titer
detect
ad
h
result
demonstr
exert
effect
step
viru
entri
cell
activ
lower
compound
figur
ad
howev
result
differ
compar
cultur
compound
remov
cultiv
period
protocol
cell
incub
drugfre
dmem
postinfect
viral
ha
titer
similar
posit
control
protocol
result
demonstr
primari
effect
four
compound
inhibit
viru
entri
cell
antivir
activ
lower
compound
ha
titer
detect
h
pi
viral
rnp
complex
import
role
viral
gener
replic
pathogen
studi
mechan
underli
inhibit
influenza
viru
strain
replic
compound
activ
rnp
combin
pa
np
influenza
viru
strain
determin
measur
luciferas
activ
minigenom
assay
shown
figur
slightli
higher
luciferas
activ
chang
observ
cultur
show
slightli
significantli
lower
activ
activ
compar
treatment
result
demonstr
activ
rnp
directli
inhibit
four
compound
result
show
ha
titer
detect
treatment
cell
infect
timeofaddit
experi
carri
explor
detail
effect
two
compound
viral
replic
result
experi
summar
figur
monolay
mdck
cell
grown
plate
moi
viru
incub
h
ensur
synchron
replic
administr
aa
accord
indic
time
interv
drugfre
dmem
replac
incub
h
supernat
harvest
end
incub
period
ha
titer
test
sever
concentr
compound
test
verifi
drug
caus
cellular
injuri
toxic
optim
dose
effect
inhibit
influenza
viru
figur
inhibitori
effect
lm
viru
observ
singl
round
replic
h
pi
viru
inhibit
ad
h
lm
signific
inhibit
observ
h
pi
inhibitori
activ
signific
compound
ad
time
interv
h
h
h
h
h
h
data
suggest
two
compound
could
affect
viru
replic
antivir
activ
compound
signific
singl
round
replic
verifi
result
two
alkaloid
inhibit
viru
replic
entri
also
evalu
whether
compound
inhibit
hemagglutin
influenza
viru
none
four
compound
inhibit
viral
attach
onto
crbc
indic
block
viral
attach
affect
ha
viral
surfac
protein
data
shown
determin
whether
na
protein
affect
alkaloid
activ
purifi
na
use
test
effect
two
compound
lm
lm
demonstr
stronger
antivir
activ
among
four
compound
test
use
neuraminidas
inhibitor
screen
kit
howev
compound
exhibit
signific
inhibitori
activ
neuraminidas
result
suggest
na
protein
target
inhibit
influenza
viru
data
shown
lm
lm
lm
oseltamivir
lm
incub
h
inocul
onto
cell
h
media
replac
drugfre
dmem
h
except
replac
media
dmem
contain
compound
adsorpt
h
cultur
contain
amaryllidacea
alkaloid
compound
mixtur
viru
moi
amaryllidacea
alkaloid
compound
ad
cell
h
replac
drugfre
dmem
h
except
replac
media
contain
drug
supernat
seven
protocol
collect
differ
time
point
h
test
ha
titer
confirm
whether
compound
inhibit
influenza
viru
entri
produc
pseudovirus
tripl
transfect
qinghai
ha
thailand
na
plasmid
hiv
backbon
plasmid
result
show
neither
could
prevent
virion
carri
ha
na
protein
bind
intern
mdck
cell
data
shown
evalu
effect
intracellular
local
viral
np
indirect
immunofluoresc
stain
perform
use
antinp
antibodi
infect
aatreat
cell
aa
nucleocapsid
protein
np
green
main
compon
rnp
complex
show
diffus
distribut
cytoplasm
h
pi
singleround
replic
multiround
replic
figur
b
compar
posit
drug
group
deriv
quercetin
member
flavonoid
could
suppress
akt
phosphoryl
figur
virusinfect
group
posit
drug
group
h
pi
distribut
np
protein
migrat
cytoplasm
protein
still
nucleu
treatment
previou
experi
demonstr
strong
inhibit
compound
singl
replic
viru
singl
replic
test
detail
aatreat
cell
viru
adsorpt
h
pi
abund
rnp
complex
assembl
nucleu
figur
treatment
cell
compound
h
rnp
stay
nucleu
figur
opposit
control
figur
note
treatment
infect
cell
differ
time
interv
affect
number
cell
posit
np
export
consist
result
indic
compound
affect
viru
entri
result
suggest
affect
migrat
rnp
complex
nucleu
cytoplasm
earli
middl
stage
replic
cycl
h
result
treatment
h
pi
np
protein
export
cytoplasm
treatment
h
p
compound
delay
protein
export
nucleu
treatment
np
protein
still
nucleu
h
pi
indic
compound
could
block
protein
export
figur
associ
signific
morbid
mortal
avian
influenza
virus
pose
seriou
public
health
threat
search
novel
drug
influenza
ongo
although
mani
plant
extract
test
research
laboratori
found
mani
lycori
alkaloid
exhibit
antivir
activ
antiinfluenza
activ
compound
l
radiata
report
studi
screen
compound
obtain
bulb
l
radiata
use
tradit
chines
medicin
found
four
compound
lycorin
hippeastrin
hemanthamin
exhibit
antiinfluenza
activ
ec
valu
lm
respect
pretreat
simultan
treatment
compound
rel
time
infect
result
signific
antivir
activ
howev
postinfect
treatment
compound
show
signific
inhibitori
effect
data
suggest
four
compound
may
interfer
viral
particl
assembl
exhibit
stronger
antivir
activ
chosen
studi
mdck
cellbas
assay
influenza
viru
particl
contain
three
protein
surfac
glycoprotein
ha
na
ionchannel
figur
hpaiv
moi
mdck
cell
either
untreat
treat
follow
aa
normal
infect
aa
treatment
control
figur
b
figur
protein
deriv
host
cellular
membran
determin
whether
amaryllidacea
alkaloid
compound
could
inhibit
function
ha
na
timeofaddit
assay
hi
assay
na
activ
assay
pseudotyp
viru
infect
assay
use
result
hi
assay
indic
compound
affect
viral
attach
ha
protein
na
activ
assay
two
compound
also
inhibit
activ
na
protein
experi
use
pseudotyp
viru
wide
use
screen
drug
resist
virus
hiv
studi
neither
could
prevent
virion
entri
howev
postinfect
treatment
result
signific
inhibit
detail
analysi
effect
time
addit
compound
data
indic
compound
significantli
inhibit
viru
singl
round
replic
viru
entri
recent
antivir
activ
lycorin
demonstr
sever
acut
respiratori
syndrom
coronoviru
sarscov
human
enteroviru
cancer
cell
also
shown
high
antiretrovir
activ
eg
lycorin
report
immunosuppressor
apoptosisresist
cancer
cell
howev
mention
antiinfluenza
activ
compound
l
radiata
never
report
found
compound
could
inhibit
influenza
viru
replic
effect
ad
earlier
infect
none
compound
affect
activ
rnp
complex
import
viral
gener
replic
migrat
nuclear
cytoplasm
block
singl
multipl
replic
treatment
compound
delay
export
np
protein
nuclear
thu
result
suggest
viral
inhibitori
activ
compound
involv
inhibit
export
rnp
complex
mani
factor
protein
nfjb
caspas
pathway
inhibit
export
rnp
complex
nuclear
cytoplasm
underli
mechan
requir
studi
addit
chemic
structur
four
compound
exhibit
antivir
activ
compound
lower
three
compound
conclus
studi
first
time
demonstr
antiinfluenza
activ
four
l
radiata
compound
particular
show
strong
activ
influenza
viru
vitro
target
outer
membran
protein
activ
rnp
complex
intern
instead
retain
antivir
activ
block
vrnp
nuclear
export
retain
antivir
activ
h
retain
even
longer
mode
action
virus
host
cell
observ
studi
impli
may
potenti
develop
antivir
agent
influenza
viru
studi
need
explor
viral
cellular
protein
pathway
target
compound
